Загрузка...
Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth
PURPOSE: Despite the advent of FDA-approved therapeutics to a limited number of available targets (kinases and mTOR), PFS of kidney cancer (RCC) has been extended only one to two years due to the development of drug resistance. Here, we evaluate a novel therapeutic for RCC which targets the exportin...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4252068/ https://ncbi.nlm.nih.gov/pubmed/25461627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113867 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|